menu
    • menu

    Company profile for Hepion Pharmaceuticals

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Hepion Pharmaceuticals (Nasdaq: HEPA) is a clinical stage biopharmaceutical company focused on the development of targeted therapies for liver disease arising from non-alcoholic steatohepatitis (NASH) and chronic hepatitis virus infection (HBV, HCV, HDV). The Company’s lead drug candidate, CRV431, reduces liver fibrosis and hepatocellular carcinoma tumor burden in experimental models of NASH. Preclinical studies also have de...
    Hepion Pharmaceuticals (Nasdaq: HEPA) is a clinical stage biopharmaceutical company focused on the development of targeted therapies for liver disease arising from non-alcoholic steatohepatitis (NASH) and chronic hepatitis virus infection (HBV, HCV, HDV). The Company’s lead drug candidate, CRV431, reduces liver fibrosis and hepatocellular carcinoma tumor burden in experimental models of NASH. Preclinical studies also have demonstrated antiviral activities towards HBV, HCV, and HDV through several mechanisms.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Hepion PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    399 Thornall Street, 1st Floor Edison, NJ 08837
    Telephone
    Telephone
    (732) 902-4000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://hepionpharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/contravir/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/HepionPharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Hepion Pharmaceuticals Completes OTCQB Application
    Hepion Pharmaceuticals Completes OTCQB Application

    25 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/25/3105087/0/en/Hepion-Pharmaceuticals-Successfully-Completes-Application-to-the-OTCQB.html

    GLOBENEWSWIRE
    25 Jun 2025
    Share Share
    Hepion Pharmaceuticals Names Dr. Kaouthar Lbiati Interim CEO
    Hepion Pharmaceuticals Names Dr. Kaouthar Lbiati Interim CEO

    16 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/16/3099830/0/en/Hepion-Pharmaceuticals-Announces-Dr-Kaouthar-Lbiati-as-Interim-Chief-Executive-Officer.html

    GLOBENEWSWIRE
    16 Jun 2025
    Share Share
    Hepion Pharmaceuticals Receives Delisting Notification from Nasdaq
    Hepion Pharmaceuticals Receives Delisting Notification from Nasdaq

    12 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/12/3079592/0/en/Hepion-Pharmaceuticals-Announces-Receipt-of-Delisting-Notification-from-Nasdaq.html

    GLOBENEWSWIRE
    12 May 2025
    Share Share
    Hepion, New Day to Commercialize Diagnostic Tests
    Hepion, New Day to Commercialize Diagnostic Tests

    07 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/07/3076133/0/en/Hepion-Pharmaceuticals-Executes-Binding-Letter-of-Intent-with-New-Day-Diagnostics-to-Commercialize-Diagnostic-Tests-for-Celiac-Disease-Respiratory-Multiplex-H-Pylori-and-HCC.html

    GLOBENEWSWIRE
    07 May 2025
    Share Share
    Hepion Pharmaceuticals Announces Reverse Stock Split
    Hepion Pharmaceuticals Announces Reverse Stock Split

    14 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/14/3042959/0/en/Hepion-Pharmaceuticals-Announces-Reverse-Stock-Split.html

    GLOBENEWSWIRE
    14 Mar 2025
    Share Share
    Hepion Pharmaceuticals Announces $9.0 Million Public Offering
    Hepion Pharmaceuticals Announces $9.0 Million Public Offering

    22 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/22/3013448/0/en/Hepion-Pharmaceuticals-Announces-9-0-Million-Public-Offering.html

    GLOBENEWSWIRE
    22 Jan 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search